Insider Trading & Ownership - Mandelia Ashish

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Mandelia Ashish
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-01-16
Sale
2024-01-17
5:20 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Chief Accounting Officer
5,025$2.71$13,618137,018
(Direct)
View
2023-01-17
Sale
2023-01-18
8:20 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
3,575$5.74$20,52196,047
(Direct)
View
2022-01-18
Sale
2022-01-19
6:19 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
1,982$5.92$11,73366,427
(Direct)
View
2021-07-01
Sale
2021-07-02
4:31 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
942$13.6$12,8110
(Direct)
View
2021-01-19
Sale
2021-01-20
7:03 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
545$21.28$11,59847,691
(Direct)
View
2021-01-04
Sale
2021-01-06
7:00 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
247$26.76$6,6100
(Direct)
View
2020-06-30
Purchase
2020-07-06
4:15 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
3,383$4.87$16,4750
(Direct)
View
2020-07-02
Sale
2020-07-06
4:15 pm
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
3,383$22.49$76,0840
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-01-15
Option Award
2024-01-17
5:20 pm
N/A
2034-01-14
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Chief Accounting Officer
91,667$0137,018
(Direct)
View
2024-01-13
Exercise
2024-01-17
5:20 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Chief Accounting Officer
12,780$0137,018
(Direct)
View
2023-09-05
Option Award
2023-09-07
5:55 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Chief Accounting Officer
30,000$030,000
(Direct)
View
2023-01-13
Option Award
2023-01-18
8:20 pm
N/A
2033-01-12
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
58,208$096,047
(Direct)
View
2023-01-14
Exercise
2023-01-18
8:20 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
10,136$096,047
(Direct)
View
2022-01-14
Option Award
2022-01-19
6:19 pm
N/A
2032-01-13
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
47,833$066,427
(Direct)
View
2022-01-14
Exercise
2022-01-19
6:19 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
10,706$066,427
(Direct)
View
2021-01-15
Option Award
2021-01-20
7:03 pm
N/A
2031-01-15
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
45,192$047,691
(Direct)
View
2021-01-15
Tax Withholding
2021-01-20
7:03 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
289$21.0947,691
(Direct)
View
2021-01-15
Exercise
2021-01-20
7:03 pm
N/A
N/A
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
834$047,691
(Direct)
View
2020-01-15
Option Award
2020-01-16
4:33 pm
N/A
2030-01-15
Mersana Therapeutics Inc.MRSNMandelia Ashish
VP, Controller
18,333$018,333
(Direct)
View